Paid Clinical Trials in Lenexa, KS
As of September 2026, 29 paid clinical trials are recruiting in Lenexa, Kansas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Lenexa offers studies at sites including GSK Investigational Site for conditions such as Obesity, Graves Disease, Healthy Volunteers, Overweight. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Lenexa
Trials by drug in Lenexa
Filter results
Newly added in Lenexa
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study of RO7890597 in Healthy Adult Volunteers
A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity
27 clinical trials
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a New Formulation of Inclisiran Containing Polysorbate 80 Compared to the Currently Marketed Formulation
A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity
Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination
A Study to Evaluate the Effects of CYP2D6 Phenotypes on the Pharmacokinetics of Xanomeline Following KarXT Administration in Healthy Adult Participants
Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants
A Study of IBI3032 in Healthy Participants
A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health
A Phase 1 Randomized, Observer-blind, Placebo-controlled, Dose-escalation Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-MARV-GP Vaccine in Adults in Good General Health
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
A Study of Investigational RSV/hMPV Combination and Investigational hMPV Vaccines in Younger and Older Adults
Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
First Time in Human Study of Long Acting VH4524184 Formulations
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection
A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age
Top Research Study Locations in Lenexa
Researchers run research studies in Lenexa, KS at 19 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| GSK Investigational Site | HIV Infections, Influenza, Human, Respiratory Syncytial Virus Infections+Metapneumovirus | 4 |
| ICON Early Phase Services, LLC | Obesity, Overweight | 2 |
| Johnson County Clin-Trials | Marburg Virus Disease, Sudan Virus Disease | 2 |
| Retina Associates, LLC | Age-Related Macular Degeneration, Age-related Macular Degeneration (AMD), Choroidal Neovascularization | 2 |
| Grifols Investigative Site | Hepatitis B Virus Infection | 1 |
| ICON (LPRA) - Lenexa | Healthy Volunteers | 1 |
| ICON - Lenexa | Healthy Volunteers | 1 |
| ICON Clinical Research | Healthy | 1 |
| ICON Clinical Research: Lenexa | Healthy Participants | 1 |
| ICON, Clinical Research Phase I Unit | Drug-Drug Interaction (DDI), FDC, Healthy Volunteer | 1 |
| Johnson County Clin-Trials (JCCT) | Cystic Fibrosis (CF), Exocrine Pancreatic Insufficiency (EPI), Pancreatic Diseases | 1 |
| Johnson County Clin-Trials, Inc. | Graves Disease, Graves' Disease | 1 |
| Johnson County Clinical Trials | Metabolic Dysfunction-Associated Steatotic Liver Disease | 1 |
| Johnson County Clintrials | Heart Failure With Mildly Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction, Obesity | 1 |
| Lenexa | Endometriosis, Uterine Fibroids | 1 |
| Lenexa Research Unit | Inclisiran Formulation | 1 |
| Overland Park Surgery Center | Lumbar Spinal Stenosis | 1 |
| Retina Associates - Lenexa | Diabetic Retinopathy | 1 |
| United Imaging Consultants | Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma | 1 |
Active & Upcoming Studies in Lenexa (2026)
Recruiting trials in Lenexa grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Diabetes & metabolic (4 active studies)
Vaccines (2 active studies)
- A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age · Phase 3 · GlaxoSmithKline
- A Study of Investigational RSV/hMPV Combination and Investigational hMPV Vaccines in Younger and Older Adults · Phase 1, Phase 2 · GlaxoSmithKline
HIV / STI (2 active studies)
- A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection · Phase 1 · GigaGen, Inc.
- First Time in Human Study of Long Acting VH4524184 Formulations · Phase 1 · ViiV Healthcare
Cardiovascular (2 active studies)
Eye & vision (2 active studies)
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003) · Phase 2, Phase 3 · EyeBiotech Ltd.
- A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy · Phase 3 · Regeneron Pharmaceuticals
Common conditions studied in Lenexa
- Obesity (3 active studies)
- Graves Disease (2 active studies)
- Healthy Volunteers (2 active studies)
- Overweight (2 active studies)
- Age-Related Macular Degeneration (1 active study)
- Age-related Macular Degeneration (AMD) (1 active study)
Leading research sponsors in Lenexa
- AstraZeneca
- GlaxoSmithKline
- International AIDS Vaccine Initiative
- Novo Nordisk A/S
- AbbVie
Frequently asked questions
How many paid clinical trials are currently recruiting in Lenexa?
There are approximately 29 recruiting clinical trials in Lenexa, Kansas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Lenexa pay participants?
Most recruiting trials in Lenexa compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Lenexa?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Lenexa?
The most common conditions under active study in Lenexa include Obesity (3), Graves Disease (2), Healthy Volunteers (2), Overweight (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Lenexa?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Lenexa on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Lenexa?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Lenexa?
Recruiting research sites in Lenexa include GSK Investigational Site, ICON Early Phase Services, LLC, Johnson County Clin-Trials, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Lenexa right now?
The largest active categories in Lenexa are Diabetes & metabolic (4), Vaccines (2), HIV / STI (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.